| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/23/2006 | WO2005059546A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 35 (gpr35) |
| 02/23/2006 | WO2005057222A3 Use of t-cadherin as a target |
| 02/23/2006 | WO2005044997A3 Identification of novel targets for radio sensitization using a genomic-based radiation sensitivity classifier |
| 02/23/2006 | WO2005028666A3 Determining kinase specificity |
| 02/23/2006 | WO2005028497A3 Receptor binding peptides derived from the sars s protein |
| 02/23/2006 | WO2005004988A3 Compositions and methods relating to novel compounds and targets thereof |
| 02/23/2006 | WO2005003372A3 Mylks as modifiers of branching morphogenesis and methods of use |
| 02/23/2006 | WO2004113914A8 System and method for coding information on a biosensor test strip |
| 02/23/2006 | WO2004110256A3 Glucose measuring module and insulin pump combination |
| 02/23/2006 | WO2004074310A3 Mycobacterial diagnostics |
| 02/23/2006 | WO2004043383A3 A new target for angiogenesis and anti-angiogenesis therapy |
| 02/23/2006 | WO2003091690A3 Cancer-associated nucleic acids and polypeptides |
| 02/23/2006 | WO2003086277A9 Attenuated gram negative bacteria |
| 02/23/2006 | WO2003072732A3 Methods of making hypermutable cells using pmsr homologs |
| 02/23/2006 | WO2003027236A3 Systems, methods and kits for remote genetic analysis and consultation |
| 02/23/2006 | US20060041400 Measurement and monitoring system of daily stock and plant |
| 02/23/2006 | US20060041386 Method of analyzing industrial food products, cosmetics, and/or hygiene products, a measurement interface for implementing the method, and an electronic system for implementing the interface |
| 02/23/2006 | US20060041058 combined with bioactive agents for a variety of purposes including drug delivery and conjugation to one member of a binding pair for use in an assay |
| 02/23/2006 | US20060040959 Adenosine A3 receptor modulators |
| 02/23/2006 | US20060040885 Bioprosthetic heart valves |
| 02/23/2006 | US20060040854 Testing the sample for abnormal, insulin-6 underexpression expression relative to a control |
| 02/23/2006 | US20060040853 Methods and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras |
| 02/23/2006 | US20060040818 Rotating seals for cell processing systems |
| 02/23/2006 | US20060040412 Indirect detection of cardiac markers for assessing acute myocardial infarction |
| 02/23/2006 | US20060040411 Light-controlled electrokinetic assembly of particles near surfaces |
| 02/23/2006 | US20060040410 Biosensor |
| 02/23/2006 | US20060040409 Measuring dissociation rate coefficient of reaction between analyte molecule immobilized on metal surface and molecule that interacts with analyte molecule by assaying changes in surface plasmon resonance signals without measuring theoretical maximum amount of binding; drug screening |
| 02/23/2006 | US20060040408 Lateral flow format, materials and methods |
| 02/23/2006 | US20060040407 Alleviation of non-specific binding in microarray assays |
| 02/23/2006 | US20060040406 Narcotic analgesic tracking system |
| 02/23/2006 | US20060040405 Test device and method for colored particle immunoassay |
| 02/23/2006 | US20060040402 System and methods for processing analyte sensor data |
| 02/23/2006 | US20060040401 Method and equipment for measuring the concentration of antiseptic solution |
| 02/23/2006 | US20060040400 adding a quenching dye capable of absorbing fluorescence of the fluorescent dye to the sample that is stained with the fluorescent dye, illuminating the sample with excitation light for the fluorescent dye, collecting and detecting fluorescence emitted from the sample |
| 02/23/2006 | US20060040395 Anti-clogging device and method for in-gel digestion applications |
| 02/23/2006 | US20060040389 Purified compositions of stem cell derived differentiating cells |
| 02/23/2006 | US20060040386 Human hepatic progenitor cells and methods of use thereof |
| 02/23/2006 | US20060040378 Device and method for quantitatively determining an analyte, a method for determining an effective size of a molecule, a method for attaching molecules to a substrate, and a device for detecting molecules |
| 02/23/2006 | US20060040376 Binding substances immobilized on surface of high refractive index; label-free; high throughput assay |
| 02/23/2006 | US20060040371 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 02/23/2006 | US20060040360 Adipocyte complement related protein homolog zacrp7 |
| 02/23/2006 | US20060040358 IGF-1 receptor interacting proteins |
| 02/23/2006 | US20060040345 Deglycosylated enzymes for conjugates |
| 02/23/2006 | US20060040341 Method of pre-treatment and staining of a biological sample and device for support of a biological sample and methods of using such device |
| 02/23/2006 | US20060040337 Method of diagnosis of pregnancy-related complications |
| 02/23/2006 | US20060040336 Containing an acetylated substrate peptide labeled with a substance which emits a signal; and a peptidase whose peptide-cleaving activity changes upon an acetylation level of the substrate peptide. |
| 02/23/2006 | US20060040335 Diagnostic and screening methods and kits associated with proteolytic activity |
| 02/23/2006 | US20060040334 Method for characterising analytes |
| 02/23/2006 | US20060040332 novel Class I HLA-A2 and Class II HLA-DR4-restricted epitopes and methods for their use in detecting T-cells in peripheral blood specific for infection or latency of mycobacterial infection, including M. tuberculosis and M. leprae as others |
| 02/23/2006 | US20060040331 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 02/23/2006 | US20060040330 Method of cancer screening |
| 02/23/2006 | US20060040329 CXCL10-based diagnosis and treatment of respiratory illnesses |
| 02/23/2006 | US20060040328 Screening for a material that promotes or inhibits binding between a rabconnectin-3-binding protein having a specific amino acid sequence and rabconnectin-3 and therefore would be useful for regulating Ca2+-dependent exocytosis |
| 02/23/2006 | US20060040326 Method for measuring reaction rate coefficient by surface plasmon resonance analysis |
| 02/23/2006 | US20060040325 Integrin antagonists with enhanced antibody dependent cell-mediated cytoxicity activity |
| 02/23/2006 | US20060040323 Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis |
| 02/23/2006 | US20060040321 Orphan receptor TLX and uses therefor |
| 02/23/2006 | US20060040319 Multiple sensor-containing active modified polypeptides, preparation and uses thereof |
| 02/23/2006 | US20060040318 Novel application of nanotechnology and sensor technologies for ex-vivo diagnostics |
| 02/23/2006 | US20060040316 Using transforming growth factor-beta -activated kinase-1 (TAK-1) and TAK1 binding protein 1(TAB-1) as evaluative tool in detection of modulators of interleukin and tumor necrosis factor activities |
| 02/23/2006 | US20060040313 Human chemokine beta-9 |
| 02/23/2006 | US20060040310 Epitope testing using soluble HLA |
| 02/23/2006 | US20060040307 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |
| 02/23/2006 | US20060040305 Non-invasive prenatal genetic diagnosis using transcervical cells |
| 02/23/2006 | US20060040302 Methods of classifying, diagnosing, stratifying and treating cancer patients and their tumors |
| 02/23/2006 | US20060040298 Rhesus monkey NURR1 nuclear receptor |
| 02/23/2006 | US20060040296 Determining in a sample from the diabetic patient presence of a polypeptide comprising (Thrombin-Activable Fibrinolysis Inhibitor, TAFI); stroke, transitory ischemic attack, atherosclerotic cerebrovascular disease and/or coronary heart disease; cardiovascular disorders |
| 02/23/2006 | US20060040294 Cleavage of nucleic acids |
| 02/23/2006 | US20060040292 Tumor markers and uses thereof |
| 02/23/2006 | US20060040285 Used in diagnosis; small cell lung cancer, lung adenocarcinoma, T-cell lymophoblastic lymphoma, glioblastoma, gastric carcinoma, colon adenocarcinoma, prostate carcinoma, pancreatic carcinoma, esophagus epidermoid carcinoma and promonocytic leukemia |
| 02/23/2006 | US20060040280 Functionalized materials and methods of using same |
| 02/23/2006 | US20060040278 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer |
| 02/23/2006 | US20060040277 Nucleic sequences encoding an AT2 receptor-interacting protein (ATIP) and their applications |
| 02/23/2006 | US20060040276 Molecular recognition at surfaces derivatized with self-assembled monolayers |
| 02/23/2006 | US20060040272 Composition comprising library of double stranded nucleic acids |
| 02/23/2006 | US20060040271 Processes for detecting or quantifying more than one nucleic acid in a library |
| 02/23/2006 | US20060040270 Processes for detecting or quantifying more than one nucleic acid in library |
| 02/23/2006 | US20060040267 Transcriptional activator |
| 02/23/2006 | US20060040266 Diagnostics and therapeutics for diseases associated with neuromedin u2 receptor (nmu2) |
| 02/23/2006 | US20060040265 Regulation of novel human asparagine-hydroxylases |
| 02/23/2006 | US20060040262 Novel compositions and methods in cancer |
| 02/23/2006 | US20060040261 Primers for isothermal amplification of hepatitis C virus |
| 02/23/2006 | US20060040259 Administering an inhibitor of prenyl cysteine methyltransferase; inhibiting the prenylation or a post-prenylation reaction of a protein contained in the virus infecting a subject |
| 02/23/2006 | US20060040258 Water-soluble conjugates and methods of preparation |
| 02/23/2006 | US20060040257 Immunoassay for HIV protease inhibitors |
| 02/23/2006 | US20060040256 Purifying testosterone from test sample by turbulent flow liquid chromatography; ionizing; detection of 2,2,4,6,6-d5 testosterone by spectrum analysis |
| 02/23/2006 | US20060040253 Use of Smad3 inhibitor in the treatment of fibrosis dependent on epithelial to mesenchymal transition as in the eye and kidney |
| 02/23/2006 | US20060040252 Prognostic tests for development of dermal stretch marks and implications for the preventive treatment thereof |
| 02/23/2006 | US20060040250 G-protein coupled receptor fusion protein is modified to include one or more sets of serine/threonine clusters, which enhance binding of such GPCR to arrestin; screening for GPCR ligands, agonists and/or antagonists |
| 02/23/2006 | US20060040249 Screening method involving transfected primary cells |
| 02/23/2006 | US20060039927 Specific binding agents for KSHV vIL-6 that neutralize a biological activity |
| 02/23/2006 | US20060039924 Peptide having modified arginine residue; detecting autoimmune antibodies against rheumatoid arthritis |
| 02/23/2006 | US20060039920 Immunization, scrub typhus of tsutsugamushi disease, HIV |
| 02/23/2006 | US20060039915 P-cadherin as a target for anti-cancer therapy |
| 02/23/2006 | US20060039907 Method and compositions for treating diseases targeting CD71 |
| 02/23/2006 | US20060039903 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 02/23/2006 | US20060039863 Use of cyanine dyes for the diagnosis of disease associated with angiogenesis |
| 02/23/2006 | US20060039862 Identification and use of growth hormone secretagogue receptor type 1A antagonists |
| 02/23/2006 | US20060039826 Concentration monitor of fluid samples |
| 02/23/2006 | US20060039002 Analysis device and analysis disc used for the same |